SCHEDULE: Vanguard Discloses 7.55% Stake in Humana

Vanguard Capital Management has reported beneficial ownership of 9,068,300 shares, representing 7.55% of Humana Inc.'s common stock as of March 31, 2026.

Summary

• Vanguard Capital Management, along with its affiliates, has disclosed a significant ownership stake in Humana Inc.
• The filing indicates beneficial ownership of 9,068,300 shares of Humana Inc. common stock.
• This holding represents 7.55% of the total class of securities.
• Vanguard Capital Management exercises sole dispositive power over 9,068,300 shares and sole voting power over 1,229,538 shares.
• The filing clarifies that this ownership includes securities held by Vanguard funds and other managed accounts where Vanguard exercises dispositive and/or voting power.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It's a routine disclosure of ownership by a major institutional investor and does not contain new operational or financial information about Humana Inc.

Positives

• Vanguard's substantial investment suggests confidence in Humana's long-term prospects.
• A large institutional holder like Vanguard can provide stability and credibility to the company.
• The disclosure confirms Vanguard's role as a significant shareholder, potentially influencing corporate governance positively.

Negatives

• The filing does not contain any negative financial or operational information about Humana Inc.

Risks

• The primary risk associated with this filing is the potential for Vanguard to alter its holdings, which could impact Humana's stock price.
• While not explicitly stated as a risk in this filing, significant ownership by a single entity can sometimes lead to concentrated decision-making.

Future Outlook

This filing is a snapshot of ownership as of March 31, 2026, and does not contain forward-looking statements or guidance from Humana Inc. itself. Vanguard's future outlook for its investment in Humana is not detailed.

Management Comments

• In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd.
• This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power.
• This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release.
• Vanguard Capital Management, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that large, passive investment managers like Vanguard often hold significant stakes in major healthcare companies like Humana. This filing indicates Vanguard's continued investment in the managed care sector, a key area within the broader healthcare industry.

Stakeholder Impact

• Shareholders: The disclosure confirms Vanguard as a significant, stable shareholder, which can be viewed positively. However, any future changes in Vanguard's holdings could impact share price.
• Management: Humana's management will be aware of Vanguard's substantial stake, which may influence strategic decisions and corporate governance considerations.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• Vanguard will continue to hold or adjust its position in Humana Inc. common stock.
• Future filings will be made if Vanguard's ownership stake changes significantly.

Key Dates

Keywords

Humana Inc, Vanguard Capital Management, Schedule 13G, SEC Filing, Beneficial Ownership, Common Stock, Institutional Investor, Healthcare, Investment Management